NEW YORK (Reuters Health) – Treatment of depression in low-income minorities with poorly controlled diabetes improved HbA1c and systolic blood pressure, investigators report in the December issue of…
NEW YORK (Reuters Health) – An investigational drug called motavizumab may offer better protection against respiratory syncytial virus (RSV) than palivizumab in high risk children, according to a…
NEW YORK (Reuters Health) – As the number of prescribed antithrombotic drugs after a first myocardial infarction increases, so does the risk of hospitalization for bleeding, according to…
NEW YORK (Reuters Health) – The use of undersized drug-eluting stents for saphenous vein graft lesions may reduce the long-term incidence of emboli and enzyme elevations without increasing…
NEW YORK (Reuters Health) – In children with bacterial meningitis, age and presenting neurologic status are the most important predictors of hearing loss, and neither dexamethasone nor glycerol…
NEW YORK (Reuters Health) – In type 2 diabetics with multiple comorbidities, tight glycemic control does not provide the same cardiovascular benefits that it does in diabetics with…
NEW YORK (Reuters Health) – The Prove-it sepsis assay (Mobidiag, Helsinki, Finland) is highly sensitive and specific in identifying bacterial species in blood samples and provides much faster…
NEW YORK (Reuters Health) – Breast cancer recurrence rates are lower with aromatase inhibitors than with tamoxifen, according to meta-analyses published online by the Journal of Clinical Oncology.…
NEW YORK (Reuters Health) – High-flow inhaled oxygen is an effective treatment for cluster headache attacks, investigators said in the Journal of the American Medical Association for December…
NEW YORK (Reuters Health) – Children who are disease-free 5 years after a cancer diagnosis are still at risk for recurrence for another 20 years or more, new…
